FEATURED

How long would you like to live, and could science and technology make it possible? Longevity science aims to extend our healthy years through advancements in CRISPR, cellular reprogramming, and drug development. While private companies and philanthropists invest heavily in these innovations, should the government be responsible for funding these efforts? Those who say yes to government funding say that longevity research could revolutionize public health, keep aging populations productive in the workforce, and reduce the economic burden of age-related…

Magic mushrooms, MDMA, and Ketamine. These psychedelic drugs, once a taboo, might not be as harmful as we thought. Some scientific studies have shown evidence that psychedelic drugs, when used in controlled therapeutic settings, may help patients with anxiety, PTSD, and depression. While states like Oregon have legalized psilocybin therapy, the FDA recently decided in a high-profile case not to approve MDMA therapy. Should doctors still consider its use, or is it overhyped? Those who advocate for psychedelic treatments argue…